Literature DB >> 33078496

Group teletherapy for first-episode psychosis: Piloting its integration with coordinated specialty care during the COVID-19 pandemic.

Helen J Wood1, Jessica M Gannon1,2, K N Roy Chengappa1,2, Deepak K Sarpal1,2.   

Abstract

Digital health has emerged in recent years as a tool to optimize care delivery and promote treatment adherence among individuals with first-episode psychosis (FEP). Recent mandates for social distancing and sheltering in place due to the COVID-19 pandemic have catapulted efforts to provide ongoing coordinated specialty care (CSC) on virtual platforms. While prior evidence provides support for the general implementation of virtual individual therapy, there is limited guidance and evidence for the adoption of group teletherapy. Here we describe our efforts to implement group teletherapy for two small cohorts of individuals with FEP receiving care in a coordinated specialty care clinic using methods adopted from Acceptance and Commitment Therapy. We observed high adherence with group visits as well as client satisfaction across groups. Based on our results, we have taken efforts to implement virtual group therapy more permanently in our clinic. Our experience provides guidance and a model for integration of virtual group therapy within CSC. PRACTITIONER POINTS: In-person group therapy can be adapted as an online treatment modality for individuals with first-episode psychosis (FEP). Group teletherapy is both accessible and satisfactory to individuals with FEP. Group teletherapy has potential as a more standard and widespread treatment modality within coordinated specialty care for FEP.
© 2020 British Psychological Society.

Entities:  

Keywords:  COVID-19; coordinated specialty care; first-episode psychosis; groups; teletherapy

Year:  2020        PMID: 33078496     DOI: 10.1111/papt.12310

Source DB:  PubMed          Journal:  Psychol Psychother        ISSN: 1476-0835            Impact factor:   3.915


  6 in total

1.  Delivery of an online psychosocial recovery program during COVID-19: A survey of young people attending a youth mental health service.

Authors:  Janaki Somaiya; Andrew Thompson; Brian O'Donoghue; Ellie Brown
Journal:  Early Interv Psychiatry       Date:  2022-02-07       Impact factor: 2.721

2.  Implementation, Adoption, and Perceptions of Telemental Health During the COVID-19 Pandemic: Systematic Review.

Authors:  Rebecca Appleton; Julie Williams; Norha Vera San Juan; Fiona Gaughran; Sonia Johnson; Justin J Needle; Merle Schlief; Harriet Jordan; Luke Sheridan Rains; Lucy Goulding; Monika Badhan; Emily Roxburgh; Phoebe Barnett; Spyros Spyridonidis; Magdalena Tomaskova; Jiping Mo; Jasmine Harju-Seppänen; Zoë Haime; Cecilia Casetta; Alexandra Papamichail; Brynmor Lloyd-Evans; Alan Simpson; Nick Sevdalis
Journal:  J Med Internet Res       Date:  2021-12-09       Impact factor: 5.428

3.  COVID-19 pandemic's effects and telehealth in Early Psychosis Services of Quebec, Canada: Will changes last?

Authors:  Paula Pires de Oliveira Padilha; Bastian Bertulies-Esposito; Sophie L'Heureux; David Olivier; Shalini Lal; Amal Abdel-Baki
Journal:  Early Interv Psychiatry       Date:  2021-10-08       Impact factor: 2.721

4.  "COVID-19 spreads round the planet, and so do paranoid thoughts". A qualitative investigation into personal experiences of psychosis during the COVID-19 pandemic.

Authors:  Minna Lyons; Ellen Bootes; Gayle Brewer; Katie Stratton; Luna Centifanti
Journal:  Curr Psychol       Date:  2021-10-12

5.  Remote group therapies for cognitive health in schizophrenia-spectrum disorders: Feasible, acceptable, engaging.

Authors:  Daniel Mendelson; Élisabeth Thibaudeau; Geneviève Sauvé; Katie M Lavigne; Christopher R Bowie; Mahesh Menon; Todd S Woodward; Martin Lepage; Delphine Raucher-Chéné
Journal:  Schizophr Res Cogn       Date:  2021-12-06

6.  Effects of an Online Solution-Focused Psychoeducation Programme on Children's Emotional Resilience and Problem-Solving Skills.

Authors:  Melih Burak Özdemir; Ayşe Bengisoy
Journal:  Front Psychol       Date:  2022-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.